Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Willemse

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 12, 2018
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)D F Hendriks, J L Willemse
Journal of Thrombosis and Haemostasis : JTH|May 4, 2011
Comparative study of commercially available procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) assaysE Heylen, J L Willemse, D F Hendriks
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttalJ L Willemse, E Heylen, D F Hendriks
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasmaJ L Willemse, J R Leurs, D F Hendriks
The South African Journal of Communication Disorders = Die Suid-Afrikaanse Tydskrif Vir Kommunikasieafwykings|January 1, 1986
The use of signs and the coding of prefix markers by teachers at a school for the deafM L Aron, R E Lewis, J L Willemse
Journal of Thrombosis and Haemostasis : JTH|September 2, 2009
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?J L Willemse, E Heylen, M E Nesheim, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Influence of the Thr325Ile polymorphism on procarboxypeptidase U (thrombin-activable fibrinolysis inhibitor) activity-based assaysJ L Willemse, V Matus, E Heylen, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2007
Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapyJ L Willemse, R Brouns, E Heylen, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcomeR Brouns, E Heylen, J L Willemse, et al.
Developmental Medicine and Child Neurology|June 1, 1977
Report of a patient with severe, chronic lactic acidaemia and pyruvate carboxylase deficiencyJ P Van Biervliet, L Bruinvis, C van der Heiden, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Haemostasis : JTH|January 12, 2018
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)D F Hendriks, J L Willemse
Journal of Thrombosis and Haemostasis : JTH|May 4, 2011
Comparative study of commercially available procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) assaysE Heylen, J L Willemse, D F Hendriks
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttalJ L Willemse, E Heylen, D F Hendriks
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasmaJ L Willemse, J R Leurs, D F Hendriks
The South African Journal of Communication Disorders = Die Suid-Afrikaanse Tydskrif Vir Kommunikasieafwykings|January 1, 1986
The use of signs and the coding of prefix markers by teachers at a school for the deafM L Aron, R E Lewis, J L Willemse
Journal of Thrombosis and Haemostasis : JTH|September 2, 2009
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?J L Willemse, E Heylen, M E Nesheim, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Influence of the Thr325Ile polymorphism on procarboxypeptidase U (thrombin-activable fibrinolysis inhibitor) activity-based assaysJ L Willemse, V Matus, E Heylen, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2007
Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapyJ L Willemse, R Brouns, E Heylen, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcomeR Brouns, E Heylen, J L Willemse, et al.
Developmental Medicine and Child Neurology|June 1, 1977
Report of a patient with severe, chronic lactic acidaemia and pyruvate carboxylase deficiencyJ P Van Biervliet, L Bruinvis, C van der Heiden, et al.
Pageof 2